Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Abemaciclib metabolite M18

Abemaciclib metabolite M18 (LSN3106729), the metabolite of Abemaciclib (HY-16297A), is a CDK inhibitor with antitumor activity. Abemaciclib metabolite M18 and a CRBN ligand have been used to design PROTAC CDK4/6 degrader[1][2].

Product Specifications

Product Name Alternative

LSN3106729

UNSPSC

12352005

Target

CDK; Ligands for Target Protein for PROTAC

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage; PROTAC

Applications

Cancer-Kinase/protease

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/abemaciclib-metabolite-m18.html

Purity

98.01

Solubility

DMSO : 7.69 mg/mL (ultrasonic; warming; heat to 60°C)

Smiles

FC(C=N1)=C(C2=CC(N(C(C)C)C(CO)=N3)=C3C(F)=C2)N=C1NC4=NC=C(C=C4)CN5CCNCC5

Molecular Formula

C25H28F2N8O

Molecular Weight

494.54

References & Citations

[1]Nathanael Gray, et al. Degradation of cyclin-dependent kinase 4/6 (cdk4/6) by conjugation of cdk4/6 inhibitors with e3 ligase ligand and methods of use. WO2017185031A1.|[2]Edward S. Kim, et al. Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non–Small Cell Lung Cancer: A Phase Ib Study.|[3]Palaniappan, et al. Abstract CT153: Pharmacokinetic drug interactions between abemaciclib and CYP3A inducers and inhibitors. Cancer Res. 2016-7-15; 76 (14_Supplement) : CT153. |[4]Goel S, et al. CDK4/6 Inhibition in Cancer: Beyond Cell Cycle Arrest. Trends Cell Biol. 2018 Nov;28 (11) :911-925. |[5]Heckler M, et al. Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation. Cancer Discov. 2021 Oct;11 (10) :2564-2581. |[6]Heckler M, et al. Inhibition of CDK4/6 Promotes CD8 T-cell Memory Formation. Cancer Discov. 2021 Oct;11 (10) :2564-2581.

Shipping Conditions

Room Temperature

Storage Conditions

-20°C, 3 years; 4°C, 2 years (Powder)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-126534/Abemaciclib-metabolite-M18-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-126534/Abemaciclib-metabolite-M18-SDS-MedChemExpress.pdf

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

CDK4; CDK6

Citation 01

Indonesian Journal of Pharmaceutics. 2025.|J Pharm Biomed Anal. 2021 Sep 5:203:114225.

CAS Number

[2704316-81-2]

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Mouse Monoclonal BTLA/CD272 Antibody (OTI2E4) [Dylight 594]
NBP2-72427DL594 0.1 mL

Mouse Monoclonal BTLA/CD272 Antibody (OTI2E4) [Dylight 594]

Ask
View Details
FFPE Tissue Blocks, Prostate
CB704190 1 Block

FFPE Tissue Blocks, Prostate

Ask
View Details
Lama1 ORF Vector (Rat) (pORF)
26270016 1.0 µg DNA

Lama1 ORF Vector (Rat) (pORF)

Ask
View Details
2-Amino-6,7-dihydrothiazolo[5,4-c]pyridin-4 (5H) -one hydrochloride
OR83552-01 100 mg

2-Amino-6,7-dihydrothiazolo[5,4-c]pyridin-4 (5H) -one hydrochloride

Ask
View Details
2-Amino-6,7-dihydrothiazolo[5,4-c]pyridin-4 (5H) -one hydrochloride
OR83552-02 250 mg

2-Amino-6,7-dihydrothiazolo[5,4-c]pyridin-4 (5H) -one hydrochloride

Ask
View Details
2-Amino-6,7-dihydrothiazolo[5,4-c]pyridin-4 (5H) -one hydrochloride
OR83552-03 1 g

2-Amino-6,7-dihydrothiazolo[5,4-c]pyridin-4 (5H) -one hydrochloride

Ask
View Details